158 related articles for article (PubMed ID: 8131854)
21. The role of water molecules in the structure-based design of (5-hydroxynorvaline)-2-cyclosporin: synthesis, biological activity, and crystallographic analysis with cyclophilin A.
Mikol V; Papageorgiou C; Borer X
J Med Chem; 1995 Aug; 38(17):3361-7. PubMed ID: 7650689
[TBL] [Abstract][Full Text] [Related]
22. Determination of the NMR solution structure of the cyclophilin A-cyclosporin A complex.
Spitzfaden C; Braun W; Wider G; Widmer H; Wüthrich K
J Biomol NMR; 1994 Jul; 4(4):463-82. PubMed ID: 8075536
[TBL] [Abstract][Full Text] [Related]
23. Expression of human cyclophilin-40 and the effect of the His141-->Trp mutation on catalysis and cyclosporin A binding.
Hoffmann K; Kakalis LT; Anderson KS; Armitage IM; Handschumacher RE
Eur J Biochem; 1995 Apr; 229(1):188-93. PubMed ID: 7744028
[TBL] [Abstract][Full Text] [Related]
24. Comparative binding studies of cyclophilins to cyclosporin A and derivatives by fluorescence measurements.
Husi H; Zurini MG
Anal Biochem; 1994 Oct; 222(1):251-5. PubMed ID: 7856857
[TBL] [Abstract][Full Text] [Related]
25. Secondary structure and backbone resonance assignments of the periplasmic cyclophilin type peptidyl-prolyl isomerase from Escherichia coli.
Clubb RT; Thanabal V; Fejzo J; Ferguson SB; Zydowsky L; Baker CH; Walsh CT; Wagner G
Biochemistry; 1993 Jun; 32(25):6391-401. PubMed ID: 8518284
[TBL] [Abstract][Full Text] [Related]
26. Improved binding affinity for cyclophilin A by a cyclosporin derivative singly modified at its effector domain.
Papageorgiou C; Florineth A; Mikol V
J Med Chem; 1994 Oct; 37(22):3674-6. PubMed ID: 7966126
[No Abstract] [Full Text] [Related]
27. Crystal structures of cyclophilin A complexed with cyclosporin A and N-methyl-4-[(E)-2-butenyl]-4,4-dimethylthreonine cyclosporin A.
Ke H; Mayrose D; Belshaw PJ; Alberg DG; Schreiber SL; Chang ZY; Etzkorn FA; Ho S; Walsh CT
Structure; 1994 Jan; 2(1):33-44. PubMed ID: 8075981
[TBL] [Abstract][Full Text] [Related]
28. Crystal structure of murine cyclophilin C complexed with immunosuppressive drug cyclosporin A.
Ke H; Zhao Y; Luo F; Weissman I; Friedman J
Proc Natl Acad Sci U S A; 1993 Dec; 90(24):11850-4. PubMed ID: 8265636
[TBL] [Abstract][Full Text] [Related]
29. Structure-based design of a cyclophilin-calcineurin bridging ligand.
Alberg DG; Schreiber SL
Science; 1993 Oct; 262(5131):248-50. PubMed ID: 8211144
[TBL] [Abstract][Full Text] [Related]
30. Analysis of cyclosporin interactions with antibodies and cyclophilin using the BIAcore.
Zeder-Lutz G; Rauffer N; Altschuh D; Van Regenmortel MH
J Immunol Methods; 1995 Jun; 183(1):131-40. PubMed ID: 7602131
[TBL] [Abstract][Full Text] [Related]
31. Structural similarity of the binding sites of cyclophilin A-cyclosporin A and FKBP-FK506 systems.
Denesyuk AI; Vihinen M; Lundell J; Zav'yalov VP; Korpela T
Biochem Biophys Res Commun; 1993 Apr; 192(2):912-7. PubMed ID: 7683466
[TBL] [Abstract][Full Text] [Related]
32. Molecular modeling studies in the complex between cyclophilin and cyclosporin A.
Gallion S; Ringe D
Protein Eng; 1992 Jul; 5(5):391-7. PubMed ID: 1518786
[TBL] [Abstract][Full Text] [Related]
33. Cyclosporin binding proteins. Identification, distribution, function and relation to FK binding proteins.
Ryffel B
Biochem Pharmacol; 1993 Jul; 46(1):1-12. PubMed ID: 8394072
[No Abstract] [Full Text] [Related]
34. Specific interaction between cyclophilin and cyclic peptides.
Gallo P; Saviano M; Rossi F; Pavone V; Pedone C; Ragone R; Stiuso P; Colonna G
Biopolymers; 1995 Sep; 36(3):273-81. PubMed ID: 7669915
[TBL] [Abstract][Full Text] [Related]
35. Cyclophilin B trafficking through the secretory pathway is altered by binding of cyclosporin A.
Price ER; Jin M; Lim D; Pati S; Walsh CT; McKeon FD
Proc Natl Acad Sci U S A; 1994 Apr; 91(9):3931-5. PubMed ID: 7909608
[TBL] [Abstract][Full Text] [Related]
36. Solvent-dependent conformation and hydrogen-bonding capacity of cyclosporin A: evidence from partition coefficients and molecular dynamics simulations.
el Tayar N; Mark AE; Vallat P; Brunne RM; Testa B; van Gunsteren WF
J Med Chem; 1993 Nov; 36(24):3757-64. PubMed ID: 8254605
[TBL] [Abstract][Full Text] [Related]
37. Active site mutants of human cyclophilin A separate peptidyl-prolyl isomerase activity from cyclosporin A binding and calcineurin inhibition.
Zydowsky LD; Etzkorn FA; Chang HY; Ferguson SB; Stolz LA; Ho SI; Walsh CT
Protein Sci; 1992 Sep; 1(9):1092-9. PubMed ID: 1338979
[TBL] [Abstract][Full Text] [Related]
38. The N-terminal cyclophilin-homologous domain of a 150-kilodalton tumor recognition molecule exhibits both peptidylprolyl cis-trans-isomerase and chaperone activities.
Rinfret A; Collins C; Ménard R; Anderson SK
Biochemistry; 1994 Feb; 33(7):1668-73. PubMed ID: 7906541
[TBL] [Abstract][Full Text] [Related]
39. X-ray structure of a monomeric cyclophilin A-cyclosporin A crystal complex at 2.1 A resolution.
Mikol V; Kallen J; Pflügl G; Walkinshaw MD
J Mol Biol; 1993 Dec; 234(4):1119-30. PubMed ID: 8263916
[TBL] [Abstract][Full Text] [Related]
40. Two new cyclophilins from Fusarium sambucinum and Aspergillus niger: resistance of cyclophilin/cyclosporin A complexes against proteolysis.
Hornbogen T; Pieper R; Hoffmann K; Kleinkauf H; Zocher R
Biochem Biophys Res Commun; 1992 Sep; 187(2):791-6. PubMed ID: 1530635
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
